J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.40.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

More than 100,000 travelers are expected to arrive at Louis Armstrong New Orleans International Airport over the next two ...

Shares of GSK PLC GSK inched up 0.94% to £14.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,557.81. GSK ...

The friendly whale might be just the design disruptor the artificial intelligence industry needs. The Chinese AI company DeepSeek is making major waves across the tech industry after rising to ...

Is it a coincidence that the Super Bowl 59 logo has the same colors as the two teams playing in the big game? Some fans don’t ...

GSK PLC closed 23.91% below its 52-week high of £18.24, which the company reached on May 16th.

Mazda’s new logo sheds 3D elements for a flat design optimized for smartphones. The updated emblem may debut ahead of Mazda’s ...

CHELMSFORD, MASSACHUSETTS / ACCESS Newswire / January 28, 2025 / (NASDAQ:HHS), a pioneer in data-driven customer experience solutions that has been transforming how companies connect with their ...

Kassa and others said Big Pharma continues to invest even as private equity funds have pulled back. He noted ...

DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...